Year Established :
2009
Total Number of Staff :
10-50
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Delivery Term,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Quality product at the best value option due to an effective pricing policy.
Flexible payment system:different payment options, letters of credit, payments after delivery; we work with USD, EURO, RUB, and RMB.
We are always around and available from any corner of the world. Modern technologies connect us with you 24 hours a day.
We provide service in many languages, such as Chinese, English, Spanish, and Russian.
Patents and Copyrights :
Keno Pharma is internationally certified by ISO 9001:2008, which confirms the right to manufacture, design, and improve the modifications of pharmaceutical products, and has a registration certificate (RU) for a line of products in the Russian Federation.
Keno Pharma Company is the exclusive supplier of sets on the Russian market.
Only we have a registration certificate for a medical product, №RZN 2018/7368, “Set for packaging of medicines.”
Business Type :
Agent,Distributor,Trading Company,Service Provider,Manufacturer
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Product Range :
- Supply of high-tech equipment for the pharmaceutical and chemical industries: Packaging, Flipping-Capping, Washing-sterilisation, Production equipment of solid forms, liquid forms and auxiliary equipment
- Production and supply of packaging and consumable items:
Medical set for packaging medicines, glass vials and ampoules, medical rubber stoppers, aluminum and laminate tubes, plastic bottles, sprayers, etc.
- Construction of pharmaceutical plants and factories on a turn-key basis
- Production and supply of substances
Glucose monohydrate, sodium lactate, xylitol, sorbitol, arginine hydrochloride, ciprofloxacin, sodium chloride, levofloxacin, metronidazole, ofloxacin, and many others.
One year of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
